Ignite Creation Date:
2025-12-25 @ 3:04 AM
Ignite Modification Date:
2025-12-26 @ 1:43 AM
Study NCT ID:
NCT06276933
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-26
First Post:
2024-02-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Camrelizumab Combined With Chemotherapy ± Thalidomide in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Sponsor:
Tongji University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-22
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-11-22
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11-22
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-16
First Submit QC Date:
None
Study First Post Date:
2024-02-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-23
Last Update Post Date:
2024-02-26
Last Update Post Date Type:
ACTUAL